FemTech

As the FemTech industry experiences significant growth in addressing the needs of women’s health, innovations are rapidly emerging to tackle the gender health gap through advanced technologies and interdisciplinary approaches.

This women-centric focus highlights previously unmet needs and supports the drive for tailored healthcare solutions. However, addressing specific conditions such as menstrual health, reproductive technology, and female oncology presents its challenges, making it imperative to develop culturally sensitive, reliable methods for diverse subpopulations of women, ensuring accessibility and efficacy of emerging technologies.

HGF’s accomplished FemTech team are experts in patent drafting, prosecution, appeals, FTO and infringement opinions, and litigation for large corporate firms, SMEs, universities, and overseas associates. Often working with experts in developmental biology, microbiome technologies, and big data technology companies, our attorneys, with backgrounds in Life Sciences, Chemistry, Electronics, Engineering, and Trade Marks, blend specialist knowledge with critical insights into rapidly evolving FemTech solutions.

We are dedicated to empowering women through innovation, ensuring that intellectual property protection generates new revenue streams, creating substantial business value, and attracting investors.

Latest updates

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article

IP Ingredients: Pouring Over the Verdict: What Thatchers v Aldi Means for Food & Drink Brands

Readers of our IP Ingredients blog may recall that we covered something of this case last summer in our post IP Ingredients: Summer case law review. The dispute between Thatchers …

Read article

Protecting inventions in Europe and beyond

A patent is  a form of registered intellectual property right granted for new, inventive and industrially applicable inventions. Patents are monopoly rights that  allow their owners (or licensees) the right …

Read article

Can intellectual property and foreign investment save struggling European eVTOL companies?

With the ongoing funding difficulties in the European eVTOL sector, we look at the role that intellectual property is likely to play in the prospects for the survival of Lilium …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our femtech specialists.